Delivery Order SPE2DU25D9439-SPE2DU26FEEFX
Award Date 3/2/26
Potential Completion Date 3/3/26
Potential Value $12K
Federal Agency
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency issued a $12,066.35 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. DMS Pharmaceutical Group Inc. is a woman-owned small business pharmaceutical wholesaler. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499.999 billion ceiling authorizing firm fixed-price delivery orders for branded and...
- The Defense Logistics Agency issued a $1,617.78 delivery order to DMS Pharmaceutical Group Inc. on February 12, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency single-award indefinite delivery contract supporting recurring pharmaceutical supply needs for Department of Defense military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned...
- The Defense Logistics Agency issued a $17,866.52 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Department of Defense healthcare operations. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract with a $499,999,999 ceiling and a December 31, 2036 ultimate completion date. DMS Pharmaceutical Group is a woman-owned small business...
- The Defense Logistics Agency issued a $9,659.15 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Defense Department medical supply needs. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract program with a $499.9 million ceiling authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter...
- The Defense Logistics Agency issued a $12,720.92 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting the supply of branded and generic prescription medications, over-the-counter drugs, biologics, vaccines, specialty pharmaceuticals, and medical consumables to...
- The Defense Logistics Agency issued a $17,896.70 delivery order to DMS Pharmaceutical Group Inc. on March 2, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products to support Defense Department medical supply requirements. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract vehicle with a $499.9 million ceiling, awarded to DMS Pharmaceutical Group on November 13, 2025, authorizing firm fixed-price delivery orders for...
- The Defense Logistics Agency issued a $4,690.14 delivery order to DMS Pharmaceutical Group Inc. on February 24, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting recurring pharmaceutical supply to military healthcare facilities worldwide. DMS Pharmaceutical Group Inc. is a woman-owned small business. Place of performance is...
- The Defense Logistics Agency issued a $151,959.24 delivery order to DMS Pharmaceutical Group Inc. on February 13, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract authorizing firm fixed-price delivery orders for branded and generic prescription drugs, over-the-counter medications, biologics, vaccines, and medical consumables to support...
- The Defense Logistics Agency issued a $2,025.60 delivery order to DMS Pharmaceutical Group Inc. on March 3, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical distribution. PPV-G GEN V is a Defense Logistics Agency indefinite delivery contract supporting pharmaceutical product supply to Department of Defense healthcare facilities worldwide. The order is firm fixed price with place of performance in Park Ridge, Illinois. Ultimate completion...
- The Defense Logistics Agency issued a $1,139.80 delivery order to DMS Pharmaceutical Group Inc. on February 17, 2026, under the Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) for pharmaceutical products and medical consumables. PPV-G GEN V is the Defense Logistics Agency's single-award indefinite delivery contract program supporting Department of Defense healthcare operations globally with firm fixed-price delivery orders for branded and generic prescription drugs,...